Cargando…

The beneficial effects of curcumin in cirrhotic rats with portal hypertension

In liver cirrhosis with portal hypertension, the uneven distribution of vasoactive substances leads to increased intrahepatic vascular resistance and splanchnic vasodilatation. Angiogenesis also induces increased portal inflow and portosystemic collaterals. The collaterals may induce lethal complica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsu, Shao-Jung, Lee, Jing-Yi, Lin, Te-Yueh, Hsieh, Yu-Hsin, Huang, Hui-Chun, Lee, Fa-Yauh, Lin, Han-Chieh, Hou, Ming-Chih, Lee, Shou-Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2017
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435472/ https://www.ncbi.nlm.nih.gov/pubmed/29162665 http://dx.doi.org/10.1042/BSR20171015

Ejemplares similares

Dual Angiotensin Receptor and Neprilysin Inhibitor Ameliorates Portal Hypertension in Portal Hypertensive Rats
por: Hsu, Shao-Jung, et al.
Publicado: (2020)

Glycyrrhizin Attenuates Portal Hypertension and Collateral Shunting via Inhibition of Extrahepatic Angiogenesis in Cirrhotic Rats
por: Pun, Chon Kit, et al.
Publicado: (2021)

Adrenal Dysfunction in Portal Hypertensive Rats with Acute Hemorrhage
por: Lee, Fa-Yauh, et al.
Publicado: (2014)

Effects of Caffeine Treatment on Hepatopulmonary Syndrome in Biliary Cirrhotic Rats
por: Chang, Ching-Chih, et al.
Publicado: (2019)

Diabetes Diminishes the Portal-Systemic Collateral Vascular Response to Vasopressin via Vasopressin Receptor and G(α) Proteins Regulations in Cirrhotic Rats
por: Lee, Jing-Yi, et al.
Publicado: (2013)

Glucobrassicin Metabolites Ameliorate the Development of Portal Hypertension and Cirrhosis in Bile Duct-Ligated Rats
por: Chang, Ting, et al.
Publicado: (2019)

Effects of PCSK-9 Inhibition by Alirocumab Treatments on Biliary Cirrhotic Rats
por: Huang, Hui-Chun, et al.
Publicado: (2022)

Matrix metalloproteinase‐9 inhibition or deletion attenuates portal hypertension in rodents
por: Huang, Hui‐Chun, et al.
Publicado: (2021)

Selective cyclooxygenase inhibition by SC-560 improves hepatopulmonary syndrome in cirrhotic rats
por: Chang, Ching-Chih, et al.
Publicado: (2017)

Mac-2 binding protein glycosylation isomer is a potential biomarker to predict portal hypertension and bacterial infection in cirrhotic patients
por: Wu, Pei-Shan, et al.
Publicado: (2021)

The Diminished Expression of Proangiogenic Growth Factors and Their Receptors in Gastric Ulcers of Cirrhotic Patients
por: Luo, Jiing-Chyuan, et al.
Publicado: (2013)

Non-cirrhotic portal hypertension in an ankylosing spondylitis patient
por: Park, Sukki, et al.
Publicado: (2018)

The Beneficial Effects of P2X(7) Antagonism in Rats with Bile Duct Ligation-induced Cirrhosis
por: Tung, Hung-Chun, et al.
Publicado: (2015)

Interobserver study on histologic features of idiopathic non-cirrhotic portal hypertension
por: Kmeid, Michel, et al.
Publicado: (2020)

Gastrointestinal Bleeding in Cirrhotic Patients with Portal Hypertension
por: Biecker, Erwin
Publicado: (2013)

Causes and Management of Non-cirrhotic Portal Hypertension
por: Gioia, Stefania, et al.
Publicado: (2020)

NAFLD Aggravates Septic Shock Due to Inadequate Adrenal Response and 11β-HSDs Dysregulation in Rats
por: Huang, Hui-Chun, et al.
Publicado: (2020)

Wall shear stress in portal vein of cirrhotic patients with portal hypertension
por: Wei, Wei, et al.
Publicado: (2017)

The Impact of Partial Splenic Embolization on Portal Hypertensive Gastropathy in Cirrhotic Patients with Portal Hypertension
por: Saeki, Michio, et al.
Publicado: (2023)

Cardiac dysfunction in cirrhotic portal hypertension with or without ascites
por: Dadhich, Sunil, et al.
Publicado: (2014)

Idiopathic non-cirrhotic portal hypertension: a review
por: Schouten, Jeoffrey NL, et al.
Publicado: (2015)

Research progress on signaling pathways in cirrhotic portal hypertension
por: Xu, Wen, et al.
Publicado: (2018)

Cirrhotic portal hypertension: From pathophysiology to novel therapeutics
por: Gunarathne, Lakmie S, et al.
Publicado: (2020)

Non-Cirrhotic Portal Hypertension in Systemic Lupus Erythematosus
por: Suárez-Díaz, Silvia, et al.
Publicado: (2023)

Statins activate the canonical hedgehog-signaling and aggravate non-cirrhotic portal hypertension, but inhibit the non-canonical hedgehog signaling and cirrhotic portal hypertension
por: Uschner, Frank E., et al.
Publicado: (2015)

Laparoscopic selective esophagogastric devascularization and splenectomy for patients with cirrhotic portal hypertension
por: Lin, Jie, et al.
Publicado: (2018)

Splenic arteriovenous fistula leading to non-cirrhotic portal hypertension: a case report: Splenic arteriovenous fistula leading to non-cirrhotic portal hypertension
por: Abou Yassine, Ahmad, et al.
Publicado: (2023)

Nitro-oxidative stress, VEGF and MMP-9 in patients with cirrhotic and non-cirrhotic portal hypertension
por: MUTI, LEON ADRIAN, et al.
Publicado: (2015)

Pathological abnormalities in splenic vasculature in non-cirrhotic portal hypertension: Its relevance in the management of portal hypertension
por: Gupta, Shahana, et al.
Publicado: (2020)

Phosphodiesterases in the Liver as Potential Therapeutic Targets of Cirrhotic Portal Hypertension
por: Kreisel, Wolfgang, et al.
Publicado: (2020)

Chronic Myeloid Leukemia Presenting as Non-cirrhotic Portal Hypertension
por: Gemnani, Rinkle R, et al.
Publicado: (2023)

Idiopathic Non-Cirrhotic Portal Hypertension and Porto-Sinusoidal Vascular Disease: Review of Current Data
por: Kmeid, Michel, et al.
Publicado: (2021)

Report of a case of cirrhotic portal hypertension with ectopic varices in the bilateral pulmonary hilar
por: Zhu, Ke, et al.
Publicado: (2022)

Protein S for Portal Vein Thrombosis in Cirrhotic Patients Waiting for Liver Transplantation
por: Hung, Hao-Chien, et al.
Publicado: (2020)

Blood Ammonia Level Correlates with Severity of Cirrhotic Portal Hypertensive Gastropathy
por: El-Kalla, Ferial, et al.
Publicado: (2018)

Systemic Mastocytosis Complicated by Non-Cirrhotic Portal Hypertension and Variceal Bleeding
por: McCarty, Thomas R., et al.
Publicado: (2017)

Identifying Patients at High Risk of Developing Non-Cirrhotic Portal Hypertension
por: Gioia, Stefania, et al.
Publicado: (2021)

Progressive dyspnoea in a patient with idiopathic non-cirrhotic portal hypertension
por: Cullivan, Sarah, et al.
Publicado: (2022)

Pregnancy in Patients with Non-cirrhotic Portal Hypertension: A Literature Review
por: Giri, Suprabhat, et al.
Publicado: (2022)

Beneficial long term effect of a phosphodiesterase-5-inhibitor in cirrhotic portal hypertension: A case report with 8 years follow-up
por: Deibert, Peter, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4dl6k2s3h8btm4l36o201t0ams